Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vitamin E and oral cancer

This article was originally published in The Tan Sheet

Executive Summary

Building on previous success in reversing "premalignant oral leukoplakia" with vitamin E preparations, Xinbin Gu, et al., Howard University (Washington, D.C.), report nutrient also "has an ability to induce oral cancer cell apoptosis through a ceramide-signaling pathway." In research using hamster oral cancer cells presented in poster abstract at AACR meeting, investigators say "these results suggested a mechanism for [vitamin E] inhibition during oral carcinogenesis that is initiated by changes in the plasma membrane of [the] transforming cell"

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092386

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel